Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199.

The emergence of Streptococcus pneumoniae serotype 19A, following use of the heptavalent pneumococcal conjugate vaccine (PCV7), has been favoured by multiple antibiotic resistance of this serotype and by other unknown factors. The aim of this study was to examine 19A isolates from invasive pneumococcal diseases (IPD) obtained before and after PCV7 implementation to ascertain which characteristics, including the presence of pili, might have favoured the emergence of this serotype in Italy. All S. pneumoniae isolates from IPD collected at the Italian National Institute of Health in the years 2001-2003 and 2006-2009 were serotyped. The 19A isolates were submitted to antimicrobial susceptibility testing by Etest and were genotyped by a combination of pulsed field gel electrophoresis (PFGE) and Multi Locus Sequence Typing (MLST). The presence of the pilus islets PI-1 and PI-2 was detected by PCR assays targeting a marker gene in each islet. The proportion of 19A isolates from IPD significantly increased from 4 % in 2001-2003 to 12 % in 2006-2009. This was largely due to the expansion of a clone characterized by sequence type (ST) 416, clonal complex (CC) 199, already present in Italy before PCV7 implementation. This clone included isolates susceptible to penicillin and containing PI-1 genes. Other CCs contributed to the emergence of serotype 19A: CC63 and CC193, already present in 2001-2003, and new-emerging CCs or clones such as CC230, CC320 and ST5204, that include drug-resistant and/or pilus-positive isolates. The expansion of serotype 19A in Italy might have been favoured not only by antibiotic resistance, but also by other bacterial factors such as the presence of pili.

[1]  A. Mccarthy.  Development , 1996, Current Opinion in Neurobiology.

[2]  T Nagatake,et al.  [Streptococcus pneumoniae]. , 1999, Nihon rinsho. Japanese journal of clinical medicine.

[3]  G. Siber,et al.  Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Steven Black,et al.  Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. , 2003, The Journal of pediatrics.

[5]  A. Pantosti,et al.  Evolution of erythromycin resistance in Streptococcus pneumoniae in Italy. , 2005, The Journal of antimicrobial chemotherapy.

[6]  R. Rappuoli,et al.  A pneumococcal pilus influences virulence and host inflammatory responses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Rappuoli,et al.  Streptococcus pneumoniae Pilus Subunits Protect Mice against Lethal Challenge , 2006, Infection and Immunity.

[8]  A. Pantosti,et al.  Antibiotic-Resistant Invasive Pneumococcal Clones in Italy , 2006, Journal of Clinical Microbiology.

[9]  A. Pantosti,et al.  The Macrolide Resistance Genes erm(B) and mef(E) Are Carried by Tn2010 in Dual-Gene Streptococcus pneumoniae Isolates Belonging to Clonal Complex CC271 , 2007, Antimicrobial Agents and Chemotherapy.

[10]  M. Ramirez,et al.  The presence of the pilus locus is a clonal property among pneumococcal invasive isolates , 2008, BMC Microbiology.

[11]  D. Crook,et al.  Vaccine Escape Recombinants Emerge after Pneumococcal Vaccination in the United States , 2007, PLoS pathogens.

[12]  R. Rappuoli,et al.  RrgA is a pilus-associated adhesin in Streptococcus pneumoniae , 2007, Molecular microbiology.

[13]  K. O'Brien,et al.  Association of the Pneumococcal Pilus with Certain Capsular Serotypes but Not with Increased Virulence , 2007, Journal of Clinical Microbiology.

[14]  M. Ramirez,et al.  Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[15]  S. Kim,et al.  Streptococcus pneumoniae Serotype 19A in Children, South Korea , 2008, Emerging infectious diseases.

[16]  W. Hanage,et al.  Streptococcus pneumoniae contains 3 rlrA pilus variants that are clonally related. , 2008, The Journal of infectious diseases.

[17]  C. Muñoz-Almagro,et al.  Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  C. Donati,et al.  A Second Pilus Type in Streptococcus pneumoniae Is Prevalent in Emerging Serotypes and Mediates Adhesion to Host Cells , 2008, Journal of bacteriology.

[19]  D. Levy-bruhl,et al.  Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  M. Ramirez,et al.  Denmark14-230 Clone as an Increasing Cause of Pneumococcal Infection in Portugal within a Background of Diverse Serotype 19A Lineages , 2009, Journal of Clinical Microbiology.

[21]  E. Bingen,et al.  Population Snapshot of Streptococcus pneumoniae Serotype 19A Isolates before and after Introduction of Seven-Valent Pneumococcal Vaccination for French Children , 2009, Journal of Clinical Microbiology.

[22]  G. Hanquet,et al.  Temporal Trends of Invasive Streptococcus pneumoniae Serotypes and Antimicrobial Resistance Patterns in Spain from 1979 to 2007 , 2009, Journal of Clinical Microbiology.

[23]  D. Low,et al.  Genome-wide dissection of globally emergent multi-drug resistant serotype 19A Streptococcus pneumoniae , 2009, BMC Genomics.

[24]  M. Lipsitch,et al.  Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. , 2010, Vaccine.

[25]  W. Schaffner,et al.  Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. , 2010, The Journal of infectious diseases.

[26]  Effect of Pneumococcal Conjugate Vaccine on Pneumococcal Meningitis , 2010 .

[27]  F. Ansaldi,et al.  Increasing Incidence of Streptococcus pneumoniae Serotype 19A and Emergence of Two Vaccine Escape Recombinant ST695 Strains in Liguria, Italy, 7 Years after Implementation of the 7-Valent Conjugated Vaccine , 2010, Clinical and Vaccine Immunology.

[28]  S. Kaplan,et al.  Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. , 2010, Vaccine.

[29]  N. Andrews,et al.  Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. , 2011, The Lancet. Infectious diseases.

[30]  D. Rolo,et al.  Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994–2009) , 2011, European Journal of Clinical Microbiology & Infectious Diseases.

[31]  I. Margarit,et al.  Genomic organization, structure, regulation and pathogenic role of pilus constituents in major pathogenic Streptococci and Enterococci. , 2011, International journal of medical microbiology : IJMM.

[32]  G. Doern,et al.  Antimicrobial Susceptibility Testing , 2011, Journal of Clinical Microbiology.

[33]  C. Whitney,et al.  Shifting genetic structure of invasive serotype 19A pneumococci in the United States. , 2011, The Journal of infectious diseases.

[34]  A. Pantosti,et al.  Serotype and Clonal Evolution of Penicillin-Nonsusceptible Invasive Streptococcus pneumoniae in the 7-Valent Pneumococcal Conjugate Vaccine Era in Italy , 2012, Antimicrobial Agents and Chemotherapy.

[35]  C. Orihuela,et al.  Prevalence and Clonal Distribution of pcpA, psrP and Pilus-1 among Pediatric Isolates of Streptococcus pneumoniae , 2012, PloS one.

[36]  M. P. van der Linden,et al.  Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German children , 2013, BMC Infectious Diseases.